Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 195,929 270,693 314,053 651,089
Total Sell Value $16,425,801 $23,384,210 $27,285,232 $61,044,052
Total People Sold 5 5 6 7
Total Sell Transactions 13 20 26 55
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 1276
  Page 34 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Davis George Eric SVP, General Counsel   •       –      –    2010-04-30 4 A $11.64 $16,943 D/D 1,456 21,908     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-30 4 A $13.23 $19,072 D/D 1,442 21,442     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-12 4 S $23.81 $22,314 D/D (937) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-12 4 OE $14.39 $13,483 D/D 937 9,018     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-05 4 S $24.63 $7,684 D/D (312) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-05 4 OE $14.00 $4,368 D/D 312 8,393     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-01 4 S $24.00 $139,974 D/D (5,833) 20,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-01 4 OE $11.05 $64,455 D/D 5,833 25,833     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-12 4 S $22.17 $20,793 D/D (938) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-12 4 OE $14.39 $13,498 D/D 938 9,019     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-03-10 4 S $22.52 $3,691,020 D/D (163,888) 60,588     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-03-10 4 OE $22.00 $3,605,536 D/D 163,888 224,476     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-08 4 S $22.14 $6,930 D/D (313) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-08 4 OE $14.00 $4,382 D/D 313 8,394     -
   Klein Joseph III Director   –       •      –    2010-03-08 4 S $22.12 $221,227 D/D (10,000) 35,000     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-08 4 S $22.11 $532,526 D/D (24,090) 19,855     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-08 4 OE $7.16 $172,484 D/D 24,090 55,361     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-03 4 S $21.00 $210,000 D/D (10,000) 31,271     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-02 4 S $21.00 $210,000 D/D (10,000) 41,271     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-02 4 S $21.00 $26,229 D/D (1,249) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-02 4 OE $14.00 $17,851 D/D 1,249 9,330     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-02-26 4 B $20.08 $16,062 D/D 800 48,740 2.81     -
   Wood Mark VP, Human Resources   •       –      –    2010-02-03 4 S $21.00 $7,917 D/D (377) 8,081     -
  1276 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 34 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us